• Home
  • About Us
    • Mission
    • History
    • Scientific Advisory Council
    • Advisory Management Committee
    • Specialist Advisors to the Executive Director
    • Member Companies
    • Participating Regulatory Authorities
    • Participating HTA and Coverage Bodies
  • Past Workshops
    • 2013-2012
    • 2011-2010
    • 2009-2008
    • 2007-2005
    • 2004-2002
  • CIRS Activities
    • Activities Schedule
    • Regulatory Programme
      • Benchmarking
      • QoDoS
    • Emerging Markets Programme
      • Emerging Markets Programme Research
    • HTA Programme
      • Research
  • Publications
    • Books
    • Journal Articles
    • Posters
    • Press Releases
    • R&D Briefings
    • White Papers
    • Workshop Synopses
  • UMBRA Initiative
    • Background
    • Methodologies
    • Regional Initiatives
    • Resources
    • UMBRA Update Newsletter
  • Member Login
  • Other Products and Services
  • Contact Us

Welcome to CIRS

About Us

About Us

Centre Activities

Members Log-in

Contact Us

Now available: R&D Briefing 53: Availability of new medicines – Characterising the factors influencing drug roll out to six markets and
R&D Briefing 54: New drug approvals in ICH countries 2004-2013.

2014 Activities Schedule

Agenda

Slide of the Month
Slide of the Month

Median time to internationalisation* for new active substances first launched 2005-2010

More...

Slide of the Month Archive •>

© 2014 CIRS (Centre for Innovation in Regulatory Science)